Bormioli Rocco Offers New Packaging
By

By
Bormioli Rocco Pharma, a Fidenza, Italy-headquartered glass and plastic manufacturer, has developed five new packaging products These products cover a way to reconstitute powder oral drugs; a streamlined freeze-drying process…

Recipharm Equips Lisbon Facility for US and EU Serialization
By

By
Recipharm, a Swedish contract development and manufacturing organization, has equipped its facility in Lisbon, Portugal with serialization capabilities ahead of US and European regulation enforcement deadlines. The facility is the…

Pfizer CentreOne Expands Contract Manufacturing in Japan
By

By
Pfizer CentreOne, a contract manufacturing organization embedded within Pfizer, is now offering services in Nagoya, Japan. The Nagoya site will provide in-country manufacture of highly potent oral solid-dosage forms. It…

Vetter To Expand Secondary Packaging Capacity
By

By
Vetter Pharma, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling and final packaging of injectables, plans to expand its secondary packaging capacities. Vetter explained the need for…

Merck KGaA Gets FDA, EMA OK for Gene Therapy Mfg Facility
By

By
Merck KGaA has completed both a US Food and Drug Administration (FDA) pre-license inspection and a European Medicines Agency (EMA) marketing authorization application inspection at its Carlsbad, California-based manufacturing facility…

Abzena Completes Cell-Line for Biosimilar
By

By
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has begun the installation of a new 500-liter single-use bioreactor as part of a series of investments in its process…

Servier CDMO Expands Chromatography Platform
By

By
Servier CDMO, the contract development and manufacturing organization (CDMO) division of Servier, a Suresnes, France-headquartered pharmaceutical company, has invested $7.5 million in chromatography technology. The investment includes continuous chromatography with…

EMD Serono Appoints Market Access SVP
By

By
EMD Serono, the biopharmaceutical business of Merck KGaA, has appointed Robert Truckenmiller as senior vice president, Market Access & Customer Solutions. Truckenmiller succeeds Scott Filosi, who was recently appointed to…

Gilead Appoints EVP, Oncology Therapeutics
By

By
Gilead Sciences has promoted Alessandro Riva, MD, to executive vice president, Oncology Therapeutics, with responsibility for Gilead’s hematology and oncology programs, including cell-therapy research and development. Riva will become a…

VBL Therapeutics Opens Gene-Therapy Mfg Facility
By

By
VBL Therapeutics, a late-stage clinical biopharmaceutical company, has opened a gene-therapy manufacturing plant at its new headquarters in Modiin, Israel. This plant will be the commercial facility for producing the…